Epigral Ltd

Epigral Ltd, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1106, marking a significant decline amid a sustained downward trend. The stock’s recent performance reflects a series of challenges impacting its valuation and market standing.

Epigral Ltd, a player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.1110 today, marking a significant milestone in its ongoing price decline. Despite a slight intraday recovery, the stock remains under pressure, reflecting persistent challenges in its financial performance and market positioning.

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Epigral Ltd, a key player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.1122 today, marking a significant milestone in its recent price trajectory. The stock has been on a downward path for six consecutive sessions, culminating in a near 10% decline over this period.

Epigral Ltd, a key player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.1143.5 today, marking a significant milestone in its ongoing decline. The stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial performance and valuation metrics.

Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1150 today, marking a significant decline amid a sustained downward trend. The stock has underperformed both its sector and the broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Epigral Ltd, a player in the Specialty Chemicals sector, has touched a fresh 52-week low of Rs.1150.75 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Epigral Ltd, a player in the Specialty Chemicals sector, experienced a marked decline today, hitting an intraday low of Rs 1,157.35. The stock underperformed its sector and broader market indices, reflecting persistent downward momentum and heightened volatility.

Epigral Ltd, a key player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.1194.3 today, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and financial performance.

Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1225.25 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and broader market indices, reflecting persistent headwinds over recent months.

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.

Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1232.8 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1263.1 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1263.1 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1313.9, marking a significant price level for the stock. This decline comes amid a broader market environment where the stock has underperformed its sector and key benchmarks over the past year.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1354.15, marking a significant decline in its stock price amid broader market dynamics and company-specific performance factors.

Epigral, a key player in the Specialty Chemicals sector, recorded a fresh 52-week low today at Rs.1376.9, reflecting a notable decline in its stock price amid broader market dynamics and company-specific performance factors.

Epigral, a small-cap player in the Specialty Chemicals sector, has undergone a revision in its market assessment reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued profitability, rising interest expenses, and a bearish technical stance, all contributing to a cautious market perspective on the stock’s near-term prospects.